Speakers:
Autumn Fogle, PharmD., PGY2 CCM Pharmacy Resident, Geisinger Medical Center - has nothing to disclose.
Moderator:
Sarah F. Hale, PharmD., BCPPS; Director of Pharmacy, Geisinger Medical Center - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Discuss the role of argatroban and eptifibatide in ischemic stroke
- Describe the results of the MOST trial and how they relate to current practice.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Sarah F. Hale, PharmD; Brain Simpkins, PharmD; Jessica Milheim, CPhT and Nichole Varela Gonzalez, PharmD have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPPA compliant.
- 1.00 ACPE
- 1.00 ACPE Tech
- 1.00 Participation Credit